aod9604 stimulates lipolysis adipocytes What Do Clinical Trials Indicate About the Fat-Burning Potential of AO – Prime Lab Peptides AOD-9604 vs MOTS-c vs Tesamorelin

doi: 10.3389/fmed.2016.00038 Received 03 July 2016 Accepted 09 August 2016 Published 23 August 2016 Volume 3 - 2016 Edited by Mohammed Morad, Clalit Health Services, Israel Reviewed by Luciana Hannibal, University Medical Center Freiburg, Germany

Clean Top of Vial Each time you draw up medication: Remove from refrigerator and allow to reach room temperature before opening the top of vial (about 10 minutes)

A mild, short reaction is common and recognised

Compounded clinical BPC-157 is tested for potency and sterility and dosed to the individual patient

Digestive system problems Nausea Mild diarrhea Cramping or gas 3